To cite this paper use one of the standards below:
Among the drugs most commonly used in judicial actions, are those used to treat diabetes mellitus, especially insulin therapy1,2. This study aimed to verify the metabolic control of fasting glucose and glycated hemoglobin in patients with type 1 diabetes mellitus (DM1) in judicialization of health, which use insulin analogues. 89 patients with DM1 acquire insulin analogues by judicialization of health in Divinópolis-MG. 43 (48.31%) participated in the study and underwent laboratory tests of fasting glucose and glycated hemoglobin levels.
53,5% were women and 72,1% used the ultra-fast insulin “aspart”. The average of the fasting glucose was 174,75 mg/dL ±70,33 and the glycated hemoglobin 8,68% ±1,65, revealing 74,4% and 88,37% patients with levels higher than those recommended, > 130 mg/dL e > 7% respectively.
It is observed that the patients in insulin analogues use, via judicial action, don’t have adequate metabolic control of DM1.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper